nad has been researched along with Dyskeratosis Congenita in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ayyar, S; Beerman, I; Bodogai, M; Bohr, VA; Fang, EF; Gong, Y; Kashyap, A; Liu, Y; Puligilla, C; Starost, MF; Stock, AJ; Sun, C; Tanaka-Yano, M; Wang, Y; Yanai, H | 1 |
| Alter, BP; Bohr, VA; Demarest, TG; Giri, N; Gong, Y; Harrington, L; Liu, Y; Savage, SA; Stock, AJ; Sun, C; Wang, K; Yang, B | 1 |
| Scheibye-Knudsen, M | 1 |
1 review(s) available for nad and Dyskeratosis Congenita
| Article | Year |
|---|---|
Neurodegeneration in accelerated aging.
Topics: Aging, Premature; Animals; Ataxia Telangiectasia; Bloom Syndrome; Cockayne Syndrome; DNA Repair; Dyskeratosis Congenita; Fanconi Anemia; Humans; Mitochondria; Mitophagy; NAD; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Progeria; Rothmund-Thomson Syndrome; Sirtuin 1; Telomere Shortening; Werner Syndrome; Xeroderma Pigmentosum | 2016 |
2 other study(ies) available for nad and Dyskeratosis Congenita
| Article | Year |
|---|---|
Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo.
Topics: Animals; Dyskeratosis Congenita; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Mice; NAD; Telomere | 2023 |
Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction.
Topics: ADP-ribosyl Cyclase 1; Animals; Brain; Cell Line; Cellular Senescence; Dyskeratosis Congenita; Female; Fibroblasts; Homeostasis; Humans; Membrane Glycoproteins; Mice; Mice, Knockout; Mitochondria; NAD; Niacinamide; Phenotype; Poly (ADP-Ribose) Polymerase-1; Pyridinium Compounds; Telomerase; Telomere | 2020 |